BREAKING
Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 2 days ago Zoom Communications Q4 2025 Earnings Results 3 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 3 days ago Synopsys Q1 2026 Earnings Results 3 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 3 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 3 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 4 days ago Earnings Preview: Best Buy (BBY) expected to report lower earnings in Q4 2026 5 days ago Apple Inc. (AAPL) Surges 5.1% — Developing Story 5 days ago Mastercard Incorporated (MA) Drops 5.6% — Developing Story 5 days ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 2 days ago Zoom Communications Q4 2025 Earnings Results 3 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 3 days ago Synopsys Q1 2026 Earnings Results 3 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 3 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 3 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 4 days ago Earnings Preview: Best Buy (BBY) expected to report lower earnings in Q4 2026 5 days ago Apple Inc. (AAPL) Surges 5.1% — Developing Story 5 days ago Mastercard Incorporated (MA) Drops 5.6% — Developing Story 5 days ago
ADVERTISEMENT
Market News

Johnson & Johnson (JNJ) Q2 2021 Earnings Call

Johnson & Johnson (NYSE: JNJ) Q2 2021 earnings call dated Jul. 21, 2021 Corporate Participants: Christopher DelOrefice — Vice President, Investor Relations Joseph J. Wolk — Executive Vice President, Chief Financial Officer Jennifer Taubert — Executive Vice President, Worldwide Chairman, Pharmaceuticals Thibaut Mongon — Executive Vice President, Worldwide Chairman, Consumer Health Ashley McEvoy — Executive Vice President, Worldwide Chairman, Medical Devices Paul Stoffels — Vice Chairman of the […]

$JNJ July 21, 2021 1 min read
NYSE
$JNJ · Earnings

Johnson & Johnson (NYSE: JNJ) Q2 2021 earnings call dated Jul. 21, 2021 Corporate Participants: Christopher DelOrefice — Vice President, Investor Relations Joseph J. Wolk — Executive Vice President, Chief Financial Officer Jennifer Taubert — Executive Vice President, Worldwide Chairman, Pharmaceuticals Thibaut Mongon — Executive Vice President, Worldwide Chairman, Consumer Health Ashley McEvoy — Executive Vice President, Worldwide Chairman, Medical Devices Paul Stoffels — Vice Chairman of the […]

· July 21, 2021

Johnson & Johnson (NYSE: JNJ) Q2 2021 earnings call dated Jul. 21, 2021

Christopher DelOrefice — Vice President, Investor Relations

Corporate Participants:

Joseph J. Wolk — Executive Vice President, Chief Financial Officer

Jennifer Taubert — Executive Vice President, Worldwide Chairman, Pharmaceuticals

Thibaut Mongon — Executive Vice President, Worldwide Chairman, Consumer Health

ADVERTISEMENT

Ashley McEvoy — Executive Vice President, Worldwide Chairman, Medical Devices

Paul Stoffels — Vice Chairman of the Executive Committee and Chief Scientific Officer

Analysts:

Louise Chen — Cantor Fitzgerald Securities — Analyst

Larry Biegelsen — Wells Fargo Securities LLC — Analyst

Chris Schott — J.P. Morgan Securities LLC — Analyst

ADVERTISEMENT

Bob Hopkins — BofA Securities, Inc. — Analyst

Joshua Jennings — Cowen and Company — Analyst

Terence Flynn — Goldman Sachs & Co. LLC — Analyst

Matt Miksic — Credit Suisse Securities (USA) LLC — Analyst

Joanne Wuensch — Citi — Analyst

ADVERTISEMENT

Jayson Bedford — Raymond James Financial Inc. — Analyst

_________

To read the full earnings call transcript, click here

ADVERTISEMENT
ADVERTISEMENT